Intraductal papillary mucinous neoplasms (IPMNs) and mucinous cystic neoplasms (MCNs) are non-invasive neoplasms that are often observed in association with invasive pancreatic cancers, but their origins and evolutionary relationships are poorly understood. In this study, we analyze 148 samples from IPMNs, MCNs, and small associated invasive carcinomas from 18 patients using whole exome or targeted sequencing. Using evolutionary analyses, we establish that both IPMNs and MCNs are direct precursors to pancreatic cancer. Mutations in SMAD4 and TGFBR2 are frequently restricted to invasive carcinoma, while RNF43 alterations are largely in non-invasive lesions. Genomic analyses suggest an average window of over three years between the developmen...
Background. Intraductal papillary mucinous neoplasms (IPMNs) are precursor lesions of pancreatic duc...
Background No previous studies have examined the possible relationship between intraductal papillary...
Pancreatic cancer, a highly aggressive tumour type with uniformly poor prognosis, exemplifies the cl...
Intraductal papillary mucinous neoplasms (IPMNs) and mucinous cystic neoplasms (MCNs) are non-invasi...
Pancreatic ductal adenocarcinoma (PDA), one of the most lethal cancers worldwide, is associated with...
Objective: Intraductal papillary mucinous neoplasms (IPMNs) are precursor lesions that can give rise...
Intraductal papillary mucinous neoplasms (IPMN) are pancreatic cystic lesions that can progress to i...
Intraductal papillary mucinous neoplasm (IPMN) is a pre-malignant, mucin-producing epithelial lesion...
Intraductal papillary mucinous neoplasms (IPMN) represent the most common cystic pre-invasive lesion...
Intraductal neoplasms are important precursors to invasive pancreatic cancer and an opportunity to d...
OBJECTIVE: To examine the clinicopathologic features and clonal relationship of multifocal intraduct...
To clarify the genetic mutations associated with intraductal papillary mucinous neoplasms (IPMN) and...
Pancreatic cystic lesions are increasingly detected in cross-sectional imaging. Intraductal papillar...
<div><p>Background</p><p>To clarify the genetic mutations associated with intraductal papillary muci...
SummaryGrowth factors have been implicated in pancreatic carcinogenesis. In this study we analyzed t...
Background. Intraductal papillary mucinous neoplasms (IPMNs) are precursor lesions of pancreatic duc...
Background No previous studies have examined the possible relationship between intraductal papillary...
Pancreatic cancer, a highly aggressive tumour type with uniformly poor prognosis, exemplifies the cl...
Intraductal papillary mucinous neoplasms (IPMNs) and mucinous cystic neoplasms (MCNs) are non-invasi...
Pancreatic ductal adenocarcinoma (PDA), one of the most lethal cancers worldwide, is associated with...
Objective: Intraductal papillary mucinous neoplasms (IPMNs) are precursor lesions that can give rise...
Intraductal papillary mucinous neoplasms (IPMN) are pancreatic cystic lesions that can progress to i...
Intraductal papillary mucinous neoplasm (IPMN) is a pre-malignant, mucin-producing epithelial lesion...
Intraductal papillary mucinous neoplasms (IPMN) represent the most common cystic pre-invasive lesion...
Intraductal neoplasms are important precursors to invasive pancreatic cancer and an opportunity to d...
OBJECTIVE: To examine the clinicopathologic features and clonal relationship of multifocal intraduct...
To clarify the genetic mutations associated with intraductal papillary mucinous neoplasms (IPMN) and...
Pancreatic cystic lesions are increasingly detected in cross-sectional imaging. Intraductal papillar...
<div><p>Background</p><p>To clarify the genetic mutations associated with intraductal papillary muci...
SummaryGrowth factors have been implicated in pancreatic carcinogenesis. In this study we analyzed t...
Background. Intraductal papillary mucinous neoplasms (IPMNs) are precursor lesions of pancreatic duc...
Background No previous studies have examined the possible relationship between intraductal papillary...
Pancreatic cancer, a highly aggressive tumour type with uniformly poor prognosis, exemplifies the cl...